AQR Capital Management »

Adverum Biotechnologies shares owned by AQR Capital Management

Quarter-by-quarter ownership of Adverum Biotechnologies (ADVM) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Adverum Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Adverum Biotechnologies held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adverum Biotechnologies by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $421k 60k 7.02

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Adverum Biotechnologies

BML Capital Management
Franklin Resources
BlackRock
VR Adviser
Frazier Life Sciences Management
5AM Venture Management
Geode Capital Management
Pale Fire Capital SE
Dimensional Fund Advisors
Northern Trust
AQR Capital Management
Charles Schwab Investment Management
Citadel Advisors
Bank of New York Mellon
Marshall Wace

View all funds holding Adverum Biotechnologies